Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
anastrozole (arimidex) (1 trial)
fulvestrant (faslodex) (1 trial)
Breast Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (2 total)